Biliary adverse events in acromegaly during somatostatin receptor ligands: predictors of onset and response to ursodeoxycholic acid treatment.
Pituitary
; 24(2): 242-251, 2021 Apr.
Article
en En
| MEDLINE
| ID: mdl-33164134
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Acromegalia
/
Receptores de Somatostatina
Tipo de estudio:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Año:
2021
Tipo del documento:
Article